The public health emergency medical countermeasures enterprise :: innovative strategies to enhance products from discovery through approval : workshop summary /
"During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasu...
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | , , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington :
National Academies Press,
©2010.
|
| Schriftenreihe: | The national academies
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health." |
| Beschreibung: | 1 online resource (xiv, 179 pages) : color illustrations |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 9780309150255 0309150256 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn650558721 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 100728s2010 dcua ob 100 0 eng d | ||
| 010 | |a 2012405814 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d MMU |d YDXCP |d IDEBK |d OCLCQ |d E7B |d VPI |d OCLCQ |d DKDLA |d ORU |d OCLCQ |d OCLCA |d OCLCF |d OCLCO |d OCLCQ |d OCLCA |d NLGGC |d OCL |d OCLCO |d OCLCQ |d OCLCO |d EBLCP |d DEBSZ |d OCLCO |d DXU |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d AZK |d OCLCO |d LOA |d OCLCA |d VT2 |d OCLCQ |d TOA |d OCLCO |d AGLDB |d MOR |d CCO |d PIFAG |d ZCU |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d NJR |d OCLCO |d MERER |d OCLCO |d OCLCA |d U3W |d OCLCA |d BUF |d OCLCO |d OCLCQ |d OCLCO |d CUY |d KIJ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d STF |d WRM |d VNS |d V5E |d OCLCQ |d VTS |d COCUF |d NRAMU |d EZ9 |d OCLCQ |d ICG |d OCLCO |d AU@ |d OCLCO |d WYU |d OCLCO |d OCLCQ |d LVT |d S9I |d TKN |d OCLCQ |d DKC |d OCLCO |d OCLCQ |d M8D |d OCLCO |d OCL |d OCLCO |d OCLCQ |d OCLCO |d UKAHL |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d AJS |d OIP |d OCLCO |d TUHNV |d INARC |d OCLCO |d OCL |d OCLCQ |d SFB |d OCL |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
| 016 | 7 | |a 101537597 |2 DNLM | |
| 019 | |a 639008311 |a 764541661 |a 768692362 |a 770820997 |a 923281822 |a 961542346 |a 962610764 |a 971068391 |a 1021270925 |a 1028768279 |a 1039222065 |a 1055338726 |a 1061014832 |a 1061048220 |a 1062861080 |a 1119432351 |a 1119455416 |a 1156373935 |a 1204383186 |a 1204390993 |a 1228538545 |a 1235840833 |a 1243599664 |a 1249243188 |a 1280744065 | ||
| 020 | |a 9780309150255 |q (electronic bk.) | ||
| 020 | |a 0309150256 |q (electronic bk.) | ||
| 020 | |z 0309150248 | ||
| 020 | |z 9780309150248 | ||
| 035 | |a (OCoLC)650558721 |z (OCoLC)639008311 |z (OCoLC)764541661 |z (OCoLC)768692362 |z (OCoLC)770820997 |z (OCoLC)923281822 |z (OCoLC)961542346 |z (OCoLC)962610764 |z (OCoLC)971068391 |z (OCoLC)1021270925 |z (OCoLC)1028768279 |z (OCoLC)1039222065 |z (OCoLC)1055338726 |z (OCoLC)1061014832 |z (OCoLC)1061048220 |z (OCoLC)1062861080 |z (OCoLC)1119432351 |z (OCoLC)1119455416 |z (OCoLC)1156373935 |z (OCoLC)1204383186 |z (OCoLC)1204390993 |z (OCoLC)1228538545 |z (OCoLC)1235840833 |z (OCoLC)1243599664 |z (OCoLC)1249243188 |z (OCoLC)1280744065 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA645.5 |b .P83 2010eb | |
| 060 | 4 | |a WA 295 | |
| 072 | 7 | |a POL |x 020000 |2 bisacsh | |
| 082 | 7 | |a 353.9/50973 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 4 | |a The public health emergency medical countermeasures enterprise : |b innovative strategies to enhance products from discovery through approval : workshop summary / |c Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington : |b National Academies Press, |c ©2010. | ||
| 300 | |a 1 online resource (xiv, 179 pages) : |b color illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 490 | 0 | |a The national academies | |
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop. | |
| 520 | |a "During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health." | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Emergency management |z United States |v Congresses. | |
| 650 | 0 | |a Public health |z United States |v Congresses. | |
| 650 | 0 | |a Emergency management |v Congresses. | |
| 650 | 0 | |a Emergency medical services. |0 http://id.loc.gov/authorities/subjects/sh85042747 | |
| 650 | 0 | |a Medical emergencies. |0 http://id.loc.gov/authorities/subjects/sh85082927 | |
| 650 | 0 | |a Public health. |0 http://id.loc.gov/authorities/subjects/sh85108638 | |
| 650 | 1 | 2 | |a Disaster Medicine |
| 650 | 2 | |a Emergency Medical Services | |
| 650 | 2 | |a Program Development | |
| 650 | 2 | 2 | |a Emergencies |
| 650 | 2 | 2 | |a Public Health |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Santé publique |z États-Unis |v Congrès. | |
| 650 | 6 | |a Services des urgences médicales. | |
| 650 | 6 | |a Urgences médicales. | |
| 650 | 6 | |a Santé publique. | |
| 650 | 7 | |a emergency medical centers. |2 aat | |
| 650 | 7 | |a public health. |2 aat | |
| 650 | 7 | |a POLITICAL SCIENCE |x Government |x State & Provincial. |2 bisacsh | |
| 650 | 7 | |a Medical emergencies |2 fast | |
| 650 | 7 | |a Emergency medical services |2 fast | |
| 650 | 7 | |a Emergency management |2 fast | |
| 650 | 7 | |a Public health |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 0 | |a Electronic books. | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026068 | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Wizemann, Theresa M. | |
| 700 | 1 | |a Stroud, Clare. | |
| 700 | 1 | |a Altevogt, Bruce M. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Medical and Public Health Preparedness for Catastrophic Events. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. | |
| 758 | |i has work: |a The public health emergency medical countermeasures enterprise (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGjRfPhFQY6Rg7F49c8FqP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Public health emergency medical countermeasures enterprise. |d Washington : National Academies Press, ©2010 |z 9780309150248 |w (OCoLC)646005428 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=326069 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36615342 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36559218 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378620 | ||
| 938 | |a ebrary |b EBRY |n ebr10395834 | ||
| 938 | |a EBSCOhost |b EBSC |n 326069 | ||
| 938 | |a YBP Library Services |b YANK |n 3411421 | ||
| 938 | |a Internet Archive |b INAR |n publichealthemer0000unse | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn650558721 |
|---|---|
| _version_ | 1816881732442390528 |
| adam_text | |
| any_adam_object | |
| author2 | Wizemann, Theresa M. Stroud, Clare Altevogt, Bruce M. |
| author2_role | |
| author2_variant | t m w tm tmw c s cs b m a bm bma |
| author_corporate | Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation |
| author_corporate_role | |
| author_facet | Wizemann, Theresa M. Stroud, Clare Altevogt, Bruce M. Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation |
| author_sort | Wizemann, Theresa M. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RA645 |
| callnumber-raw | RA645.5 .P83 2010eb |
| callnumber-search | RA645.5 .P83 2010eb |
| callnumber-sort | RA 3645.5 P83 42010EB |
| callnumber-subject | RA - Public Medicine |
| collection | ZDB-4-EBA |
| contents | Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop. |
| ctrlnum | (OCoLC)650558721 |
| dewey-full | 353.9/50973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 353 - Specific fields of public administration |
| dewey-raw | 353.9/50973 |
| dewey-search | 353.9/50973 |
| dewey-sort | 3353.9 550973 |
| dewey-tens | 350 - Public administration and military science |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08869cam a2200973 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn650558721</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">100728s2010 dcua ob 100 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2012405814</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MMU</subfield><subfield code="d">YDXCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">E7B</subfield><subfield code="d">VPI</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKDLA</subfield><subfield code="d">ORU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DXU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LOA</subfield><subfield code="d">OCLCA</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">CCO</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">NJR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERER</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">CUY</subfield><subfield code="d">KIJ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">VNS</subfield><subfield code="d">V5E</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">LVT</subfield><subfield code="d">S9I</subfield><subfield code="d">TKN</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">AJS</subfield><subfield code="d">OIP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TUHNV</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SFB</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101537597</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">639008311</subfield><subfield code="a">764541661</subfield><subfield code="a">768692362</subfield><subfield code="a">770820997</subfield><subfield code="a">923281822</subfield><subfield code="a">961542346</subfield><subfield code="a">962610764</subfield><subfield code="a">971068391</subfield><subfield code="a">1021270925</subfield><subfield code="a">1028768279</subfield><subfield code="a">1039222065</subfield><subfield code="a">1055338726</subfield><subfield code="a">1061014832</subfield><subfield code="a">1061048220</subfield><subfield code="a">1062861080</subfield><subfield code="a">1119432351</subfield><subfield code="a">1119455416</subfield><subfield code="a">1156373935</subfield><subfield code="a">1204383186</subfield><subfield code="a">1204390993</subfield><subfield code="a">1228538545</subfield><subfield code="a">1235840833</subfield><subfield code="a">1243599664</subfield><subfield code="a">1249243188</subfield><subfield code="a">1280744065</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309150255</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309150256</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309150248</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309150248</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)650558721</subfield><subfield code="z">(OCoLC)639008311</subfield><subfield code="z">(OCoLC)764541661</subfield><subfield code="z">(OCoLC)768692362</subfield><subfield code="z">(OCoLC)770820997</subfield><subfield code="z">(OCoLC)923281822</subfield><subfield code="z">(OCoLC)961542346</subfield><subfield code="z">(OCoLC)962610764</subfield><subfield code="z">(OCoLC)971068391</subfield><subfield code="z">(OCoLC)1021270925</subfield><subfield code="z">(OCoLC)1028768279</subfield><subfield code="z">(OCoLC)1039222065</subfield><subfield code="z">(OCoLC)1055338726</subfield><subfield code="z">(OCoLC)1061014832</subfield><subfield code="z">(OCoLC)1061048220</subfield><subfield code="z">(OCoLC)1062861080</subfield><subfield code="z">(OCoLC)1119432351</subfield><subfield code="z">(OCoLC)1119455416</subfield><subfield code="z">(OCoLC)1156373935</subfield><subfield code="z">(OCoLC)1204383186</subfield><subfield code="z">(OCoLC)1204390993</subfield><subfield code="z">(OCoLC)1228538545</subfield><subfield code="z">(OCoLC)1235840833</subfield><subfield code="z">(OCoLC)1243599664</subfield><subfield code="z">(OCoLC)1249243188</subfield><subfield code="z">(OCoLC)1280744065</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA645.5</subfield><subfield code="b">.P83 2010eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WA 295</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">POL</subfield><subfield code="x">020000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">353.9/50973</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="4"><subfield code="a">The public health emergency medical countermeasures enterprise :</subfield><subfield code="b">innovative strategies to enhance products from discovery through approval : workshop summary /</subfield><subfield code="c">Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2010.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiv, 179 pages) :</subfield><subfield code="b">color illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">The national academies</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health."</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Emergency management</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Public health</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Emergency management</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Emergency medical services.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85042747</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical emergencies.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85082927</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Public health.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85108638</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Disaster Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Emergency Medical Services</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Program Development</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Emergencies</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Public Health</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Santé publique</subfield><subfield code="z">États-Unis</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Services des urgences médicales.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Urgences médicales.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Santé publique.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">emergency medical centers.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">public health.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">POLITICAL SCIENCE</subfield><subfield code="x">Government</subfield><subfield code="x">State & Provincial.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical emergencies</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Emergency medical services</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Emergency management</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Public health</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wizemann, Theresa M.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stroud, Clare.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Altevogt, Bruce M.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Medical and Public Health Preparedness for Catastrophic Events.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">The public health emergency medical countermeasures enterprise (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGjRfPhFQY6Rg7F49c8FqP</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Public health emergency medical countermeasures enterprise.</subfield><subfield code="d">Washington : National Academies Press, ©2010</subfield><subfield code="z">9780309150248</subfield><subfield code="w">(OCoLC)646005428</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=326069</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36615342</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36559218</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3378620</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10395834</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">326069</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3411421</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">publichealthemer0000unse</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Electronic books. Congress proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf |
| genre_facet | Electronic books. Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| geographic | United States United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocn650558721 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:17:24Z |
| institution | BVB |
| isbn | 9780309150255 0309150256 |
| language | English |
| lccn | 2012405814 |
| oclc_num | 650558721 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xiv, 179 pages) : color illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | National Academies Press, |
| record_format | marc |
| series2 | The national academies |
| spelling | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. Washington : National Academies Press, ©2010. 1 online resource (xiv, 179 pages) : color illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda The national academies Includes bibliographical references. Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop. "During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health." Print version record. Emergency management United States Congresses. Public health United States Congresses. Emergency management Congresses. Emergency medical services. http://id.loc.gov/authorities/subjects/sh85042747 Medical emergencies. http://id.loc.gov/authorities/subjects/sh85082927 Public health. http://id.loc.gov/authorities/subjects/sh85108638 Disaster Medicine Emergency Medical Services Program Development Emergencies Public Health United States Santé publique États-Unis Congrès. Services des urgences médicales. Urgences médicales. Santé publique. emergency medical centers. aat public health. aat POLITICAL SCIENCE Government State & Provincial. bisacsh Medical emergencies fast Emergency medical services fast Emergency management fast Public health fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Electronic books. Congress proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf Wizemann, Theresa M. Stroud, Clare. Altevogt, Bruce M. Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. has work: The public health emergency medical countermeasures enterprise (Text) https://id.oclc.org/worldcat/entity/E39PCGjRfPhFQY6Rg7F49c8FqP https://id.oclc.org/worldcat/ontology/hasWork Print version: Public health emergency medical countermeasures enterprise. Washington : National Academies Press, ©2010 9780309150248 (OCoLC)646005428 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=326069 Volltext |
| spellingShingle | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop. Emergency management United States Congresses. Public health United States Congresses. Emergency management Congresses. Emergency medical services. http://id.loc.gov/authorities/subjects/sh85042747 Medical emergencies. http://id.loc.gov/authorities/subjects/sh85082927 Public health. http://id.loc.gov/authorities/subjects/sh85108638 Disaster Medicine Emergency Medical Services Program Development Emergencies Public Health Santé publique États-Unis Congrès. Services des urgences médicales. Urgences médicales. Santé publique. emergency medical centers. aat public health. aat POLITICAL SCIENCE Government State & Provincial. bisacsh Medical emergencies fast Emergency medical services fast Emergency management fast Public health fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85042747 http://id.loc.gov/authorities/subjects/sh85082927 http://id.loc.gov/authorities/subjects/sh85108638 http://id.loc.gov/authorities/genreForms/gf2014026068 |
| title | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / |
| title_auth | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / |
| title_exact_search | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / |
| title_full | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_fullStr | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_full_unstemmed | The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_short | The public health emergency medical countermeasures enterprise : |
| title_sort | public health emergency medical countermeasures enterprise innovative strategies to enhance products from discovery through approval workshop summary |
| title_sub | innovative strategies to enhance products from discovery through approval : workshop summary / |
| topic | Emergency management United States Congresses. Public health United States Congresses. Emergency management Congresses. Emergency medical services. http://id.loc.gov/authorities/subjects/sh85042747 Medical emergencies. http://id.loc.gov/authorities/subjects/sh85082927 Public health. http://id.loc.gov/authorities/subjects/sh85108638 Disaster Medicine Emergency Medical Services Program Development Emergencies Public Health Santé publique États-Unis Congrès. Services des urgences médicales. Urgences médicales. Santé publique. emergency medical centers. aat public health. aat POLITICAL SCIENCE Government State & Provincial. bisacsh Medical emergencies fast Emergency medical services fast Emergency management fast Public health fast |
| topic_facet | Emergency management United States Congresses. Public health United States Congresses. Emergency management Congresses. Emergency medical services. Medical emergencies. Public health. Disaster Medicine Emergency Medical Services Program Development Emergencies Public Health United States Santé publique États-Unis Congrès. Services des urgences médicales. Urgences médicales. Santé publique. emergency medical centers. public health. POLITICAL SCIENCE Government State & Provincial. Medical emergencies Emergency medical services Emergency management Public health Electronic books. Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=326069 |
| work_keys_str_mv | AT wizemanntheresam thepublichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT stroudclare thepublichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT altevogtbrucem thepublichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT instituteofmedicineusforumonmedicalandpublichealthpreparednessforcatastrophicevents thepublichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation thepublichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT wizemanntheresam publichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT stroudclare publichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT altevogtbrucem publichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT instituteofmedicineusforumonmedicalandpublichealthpreparednessforcatastrophicevents publichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation publichealthemergencymedicalcountermeasuresenterpriseinnovativestrategiestoenhanceproductsfromdiscoverythroughapprovalworkshopsummary |